Sinew Pharma Inc. (TPEX:6634)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
60.00
+2.20 (3.81%)
Oct 16, 2026, 1:06 PM CST

Sinew Pharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,2562,7923,3924,7987,3265,659
Market Cap Growth
35.01%-17.69%-29.30%-34.51%29.47%19.05%
Enterprise Value
3,2731,7072,1853,4685,8954,354
Last Close Price
59.7039.1547.5567.70105.0082.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
90552.1159405.82--22335.55908.45
PB Ratio
4.102.562.833.635.023.61
P/TBV Ratio
4.162.602.893.735.223.77

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-36314.06--17973.83699.01

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.000.010.010.00
Net Debt / Equity Ratio
-0.95-0.95-0.97-0.96-0.95-0.94
Net Debt / EBITDA Ratio
7.708.167.987.7410.7920.06
Net Debt / FCF Ratio
10.0010.8110.8810.1113.9824.90
Asset Turnover
00--00.01
Quick Ratio
46.3542.2343.4336.7860.5499.08
Current Ratio
46.4342.2843.4636.8160.5699.36
Return on Equity (ROE)
-10.85%-10.81%-11.93%-12.29%-9.26%-9.14%
Return on Assets (ROA)
-7.40%-7.44%-8.15%-8.17%-6.04%-5.79%
Return on Capital Employed (ROCE)
-12.70%-12.70%-14.10%-14.00%-10.10%-6.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.78%-4.43%-4.43%-3.56%-1.91%-1.62%
FCF Yield
-2.31%-3.44%-3.13%-2.61%-1.35%-1.05%
Buyback Yield / Dilution
-0.08%0.37%-1.21%-1.68%-16.47%-19.41%